Medtronic’s all-in-one mapping and ablation system gains expanded CE mark approval | Cardiovascular Business
NEW27 days ago|Discuss (0)|Business
Article written by Cardiovascular Business
Medtronic has received expanded CE mark approval for its Affera Mapping and Ablation System, allowing treatment for ventricular arrhythmias. The device has also received FDA fast-track designation, potentially speeding up its approval process in the U.S.
Read full story @ cardiovascularbusiness.com/topics/clinical/heart-rhythm/medtronics-all-one-mapping-and-ablation-system-gains-expanded-ce-mark-approval »
NewzGrade: 90 [A-]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
90A-
FDCBA
SPAG95
Coherent90
Objective90
Sourced85
Concise90
Graded by NewzGrade AI AI · provisional on August 08, 2026 at 03:27 AM
90A-
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 95 | 90 | 90 | 85 | 90 |
90A-grade breakdown
SPAG
95
Coherent
90
Objective
90
Sourced
85
Concise
90
The article effectively presents detailed and factual reporting typical of news writing, though the sourcing could be clearer in some areas. Overall, it maintains a solid structure and flow, effectively conveying the approval and implications of Medtronic's new device.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
